Start Over

MEIS and PBX homeobox proteins in ovarian cancer.

Authors :: Crijns AP
de Graeff P
Geerts D
Ten Hoor KA
Hollema H
van der Sluis T
Hofstra RM
de Bock GH
de Jong S
van der Zee AG
de Vries EG
Source :: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2007 Nov; Vol. 43 (17), pp. 2495-505. Date of Electronic Publication: 2007 Oct 18.
Publication Year :: 2007
Abstract: Three amino-acid loop extension (TALE) homeobox proteins MEIS and PBX are cofactors for HOX-class homeobox proteins, which control growth and differentiation during embryogenesis and homeostasis. We showed that MEIS and PBX expression are related to cisplatin resistance in ovarian cancer cell lines. Therefore, MEIS1, MEIS2 and PBX expression were investigated immunohistochemically in a tissue microarray (N=232) of ovarian cancers and ovarian surface epithelium (N=15). Results were related to clinicopathologic characteristics and survival. All cancers expressed MEIS1, MEIS2 and PBX in nucleus and cytoplasm. MEIS1 and 2 only stained nuclear in surface epithelium. Nuclear MEIS2 was negatively related to stage, grade and overall survival in univariate analyses. Additionally, MEIS and PBX RNA expression in ovarian surface epithelium and other normal tissues and ovarian cancer versus other tumour types using public array data sets were studied. In ovarian cancer, MEIS1 is highly expressed compared to other cancer types. In conclusion, MEIS and PBX are extensively expressed in ovarian carcinomas and may play a role in ovarian carcinogenesis.